1st Xarelto MDL Bellwether Trial Ends In Defense Verdict For Bayer, Janssen
NEW ORLEANS — The first Xarelto multidistrict litigation bellwether trial ended May 3 with a defense verdict for co-defendants Janssen Pharmaceuticals Inc. and Bayer Pharma AG (In Re: Xarelto Products Liability...To view the full article, register now.
Already a subscriber? Click here to view full article